Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gebel

Showing results (261-270 of 294) with videos related to

Pageof 30
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|February 4, 2016
Allocating Deceased Donor Kidneys to Candidates with High Panel-Reactive AntibodiesHoward M Gebel, Bertram L Kasiske, Sally K Gustafson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 26, 2013
Class II alloantibody and mortality in simultaneous liver-kidney transplantationJ G O'Leary, H M Gebel, R Ruiz, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|February 24, 1999
Sonography under Daylight ConditionsJ S Bleck, M Gebel, B Witt, et al.
Clinical Transplantation|February 2, 2022
Immunogenicity after heterologous third dose COVID-19 vaccination in a heart transplant recipientSapna A Mehta, Alex Reyentovich, Robert A Montgomery, et al.
Zeitschrift Fur Gastroenterologie|December 26, 2001
[Intestinal tuberculosis: Easier overlooked than diagnosed]M N Göke, A Leppert, P Flemming, et al.
Transplant Immunology|September 24, 2022
Development of donor specific antibodies after SARS-CoV-2 vaccination in kidney and heart transplant recipientsThomas R McCune, Robert A Bray, David A Baran, et al.
Archives of Pathology & Laboratory Medicine|February 25, 2017
Genotyping Applications for Transplantation and Transfusion Management: The Emory ExperienceRoss M Fasano, Harold Cliff Sullivan, Robert A Bray, et al.
Transplantation|April 16, 2004
Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokineticsCarlos A Vieira, Avinash Agarwal, Benita K Book, et al.
Transplantation|September 7, 2022
Analysis of Cross-sectional and Longitudinal HLA and Anti-viral Responses After COVID Infection in Renal Allograft Recipients: Differences and CorrelatesAlin L Girnita, Lin Wang, Adriana I Colovai, et al.
Kidney International|February 16, 2020
Epitopes as characterized by antibody-verified eplet mismatches determine risk of kidney transplant lossRuth Sapir-Pichhadze, Xun Zhang, Abdelhakim Ferradji, et al.
Pageof 30

Showing results (261-270 of 294) with videos related to

Sort By:
Pageof 30
Clinical Journal of the American Society of Nephrology : CJASN|February 4, 2016
Allocating Deceased Donor Kidneys to Candidates with High Panel-Reactive AntibodiesHoward M Gebel, Bertram L Kasiske, Sally K Gustafson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 26, 2013
Class II alloantibody and mortality in simultaneous liver-kidney transplantationJ G O'Leary, H M Gebel, R Ruiz, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|February 24, 1999
Sonography under Daylight ConditionsJ S Bleck, M Gebel, B Witt, et al.
Clinical Transplantation|February 2, 2022
Immunogenicity after heterologous third dose COVID-19 vaccination in a heart transplant recipientSapna A Mehta, Alex Reyentovich, Robert A Montgomery, et al.
Zeitschrift Fur Gastroenterologie|December 26, 2001
[Intestinal tuberculosis: Easier overlooked than diagnosed]M N Göke, A Leppert, P Flemming, et al.
Transplant Immunology|September 24, 2022
Development of donor specific antibodies after SARS-CoV-2 vaccination in kidney and heart transplant recipientsThomas R McCune, Robert A Bray, David A Baran, et al.
Archives of Pathology & Laboratory Medicine|February 25, 2017
Genotyping Applications for Transplantation and Transfusion Management: The Emory ExperienceRoss M Fasano, Harold Cliff Sullivan, Robert A Bray, et al.
Transplantation|April 16, 2004
Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokineticsCarlos A Vieira, Avinash Agarwal, Benita K Book, et al.
Transplantation|September 7, 2022
Analysis of Cross-sectional and Longitudinal HLA and Anti-viral Responses After COVID Infection in Renal Allograft Recipients: Differences and CorrelatesAlin L Girnita, Lin Wang, Adriana I Colovai, et al.
Kidney International|February 16, 2020
Epitopes as characterized by antibody-verified eplet mismatches determine risk of kidney transplant lossRuth Sapir-Pichhadze, Xun Zhang, Abdelhakim Ferradji, et al.
Pageof 30